Guillemant S, Prier A, Guillemant J, Massin J P, Camus J P
Rev Rhum Mal Osteoartic. 1982 Feb;49(2):93-8.
This study involved three adult men and six elderly individuals (3 men and 3 women). Adult subjects served as the control group. All subjects were given one dose of 10 microCi of tritiated vitamin D3 (approximately 15 IU) per os. Blood samples were taken 5 min., 1 h, 2 h, 3 h, 4 h, 6 h, 8 h, 24 h, 48 h, 72 h, 96 h, 120 h, 144 h, 168 h and 192 h after administration of vitamin D3. The concentrations of tritiated vitamin D3 and 25-hydroxyvitamin D3, its principal metabolite, were measured in each sample after extraction and purification by high performance liquid chromatography (HPLC). In addition, two adult subjects and three elderly women subjects were given an identical dose of tritiated vitamin D3 approximately 10 days following the end of the initial experience. Blood samples were collected at the times indicated above and analyzed in identical fashion. The percentage of intestinal absorption of vitamin D3 and the amount of vitamin D3 metabolized to 25-hydroxyvitamin D3 were calculated as were the time constants for vitamin D3 and 25-hydroxyvitamin D3 disappearance curves. Review of these parameters confirmed that significant individual variations exist for intestinal absorption of vitamin D3. Study results did not furnish any evidence of a decrease in 25-hydroxylation of vitamin D3, nor any increase in the rate of disappearance of vitamin D3 or 25-hydroxyvitamin D3 which might explain the very low levels of 25-hydroxyvitamin D3, often found in aged persons.
本研究纳入了3名成年男性和6名老年人(3名男性和3名女性)。成年受试者作为对照组。所有受试者口服一剂10微居里的氚化维生素D3(约15国际单位)。在给予维生素D3后5分钟、1小时、2小时、3小时、4小时、6小时、8小时、24小时、48小时、72小时、96小时、120小时、144小时、168小时和192小时采集血样。通过高效液相色谱法(HPLC)提取和纯化后,测定每个样本中氚化维生素D3及其主要代谢产物25-羟基维生素D3的浓度。此外,在初次试验结束约10天后,给2名成年受试者和3名老年女性受试者给予相同剂量的氚化维生素D3。按上述时间采集血样并以相同方式进行分析。计算维生素D3的肠道吸收百分比以及代谢为25-羟基维生素D3的维生素D3量,同时计算维生素D3和25-羟基维生素D3消失曲线的时间常数。对这些参数的审查证实,维生素D3的肠道吸收存在显著个体差异。研究结果未提供任何证据表明维生素D3的25-羟化作用降低,也未发现维生素D3或25-羟基维生素D3消失速率增加,而这可能解释老年人中经常发现的25-羟基维生素D3水平极低的现象。